RY 169.88 -1.0542% SHOP 144.59 -0.959% TD 77.85 -0.1667% ENB 59.62 -0.5505% BN 78.53 -0.971% TRI 223.92 -0.2495% CNQ 47.03 -0.0213% CP 102.49 -0.5627% CNR 147.77 -0.8787% BMO 131.32 -0.0685% BNS 78.4 0.0255% CSU 4463.7002 0.6222% CM 90.42 0.6344% MFC 44.91 -1.3184% ATD 77.0 -0.7604% NGT 60.01 -0.4149% TRP 68.0 -2.2989% SU 56.965 -0.4282% WCN 260.14 -0.653% L 176.45 0.7135%
Neo Performance Materials Inc. (TSX: NEO) is engaged in the innovation, development, processing, and manufacturing of rare earth and rare metal-based functional materials. The group’s operating segments include Magnequench, Chemicals & Oxides and Rare Metals.
Key Investment Rationale:
Risks associated with the investment:
The company’s operations might be hindered on account of a lower level of activities from the end market due to several reasons like semiconductor chip shortage, lower corporate order book, sluggish demand for technology and related products etc.
FY21 Financial Highlights: (in thousands USD)
FY21 Income Statement Highlights (Source: Company Report)
Source: Company Report
Top-10 Shareholders: Top ten shareholders of the company together hold approximately 51.62% stake, Oaktree Capital Management, L.P. and Mawer Investment Management Ltd. are the major shareholders in the company with an outstanding position of 24.28% and 12.66%, respectively.
Source: REFINITIV, Analysis by Kalkine Group
Valuation Methodology (Illustrative): EV to Sales based\
Analysis by Kalkine Group
*% Premium/(Discount) is based on our assessment of the company’s NTM trading multiple after considering its key growth drivers, economic moat, stock's historical trading multiples versus peer average/median, and investment risks.
Stock Recommendation:
In FY21, the company has shown significant volume recoveries from the prior year as COVID-19 related issues continue to diminish, which is encouraging. Hence, in FY21, the corporation reported robust growth from all its operating segments, which has resulted in strong performance metrics. Notably, consolidated adjusted EBITDA was recorded at USD 81.9 million, which soared from USD 28.8 million in FY20. The company has long standing relationships with industry leaders and OEM’ clients, and offers value proposition for them, which would continue to support the company’s upcoming order-book as well. We have valued the stock using the EV to Sales based relative valuation method and have arrived at a double-digit upside (in percentage terms). For the said purposes, we have considered peers like SNC-Lavalin Group Inc, 5N Plus Inc etc. Considering the aforesaid facts, we recommend a ‘Buy’ rating on the stock of NEO at the last closing price of CAD 15.87 on March 25, 2022. Markets are trading in a highly volatile zone currently due to certain macro-economic issues and geopolitical tensions prevailing. Therefore, it is prudent to follow a cautious approach while investing
One-Year Technical Price Chart (as on March 25, 2022). Source: REFINITIV, Analysis by Kalkine Group
*Recommendation is valid on March 28, 2022, price as well
Technical Analysis Summary
Disclaimer
The advice given by Kalkine Canada Advisory Services Inc. and provided on this website is general information only and it does not take into account your investment objectives, financial situation and the particular needs of any particular person. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. The website www.kalkine.ca is published by Kalkine Canada Advisory Services Inc. The link to our Terms & Conditions has been provided please go through them. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.